Specimen · QD-6WF3Medical imaging

Screening mammograms with BI-RADS reports

2D screening views with tomosynthesis where acquired; BI-RADS in every report, biopsy outcome on a linked subset.

Size
10,000 to 50,000 studies
Years
2018 to 2025
Modality
Mammography
Geography
India
Status
Licensed

Where this listing stands.

Every listing moves along the same four stations. This one is at licensed.

  1. 01ListedThe deal sheet is public. Ask questions; the owner is named after NDA.
  2. 02Sample readyA sample is cut and cleared. Accept the click-through NDA to get an expiring link.
  3. 03Under NDAA lab is evaluating the sample. Others can still request one unless the listing is exclusive.
  4. 04LicensedLicensed and delivered. Non-exclusive listings stay open for new licences.(current)

01 Composition

Size
10,000 to 50,000 studies (studies on request)
Years covered
2018 to 2025
Views
CC and MLO; tomosynthesis on a subset
Reports
BI-RADS 0 to 6
Linked data
Biopsy outcome, prior screens
1416182022242526

02 Data spec

Images
Full DICOM series, one folder per study, series subfolders
Reports
Radiology report per study, free-text redacted
Metadata
Modality, body part, manufacturer and model, acquisition parameters, age band, sex, region of site

03 De-identification

Runs on site before export. DICOM headers cleaned to the PS3.15 confidentiality profile, burned-in text masked, reports redacted, dates shifted per patient, pseudonymous IDs keep studies linked. Report shared after NDA.

What the imaging de-identification report contains

04 Provenance

Owner type
Hospital network
Rights basis
Owner-held rights; ethics approval reviewed
Owner identity
Named after NDA

05 Licence options

Exclusivity
Non-exclusive
Term
3 years
Territory
Worldwide
Permitted use
Training, evaluation

06 Commercials

On request